microfluidic device preparation Search Results


90
AIM Biotech microfluidic devices
(A) Schematic layout of the <t>microfluidic</t> device to perform 3D co-culture of B16 melanoma cells and T cells from Themis cWT or cKO OT-I mice treated with tamoxifen (TX). The central channel (in purple) represents the tumor region, whereas the lateral channels (in cyan) provide nutrients and allow for CTL injection. (B) Zoomed-in schematic of the microfluidic system. Target melanoma cells were embedded in an extracellular matrix-like hydrogel and inserted in the central microchannel flanked by two lateral channels containing cell culture medium and CTL. Live and dead B16 melanoma cells are shown in green and red, respectively. CTL are shown in blue. (C) Scatter plot of the percentage of dead B16–OVA cells after 24 h from the injection of OT-I Themis cWT or cKO TX CTL in the fluidic microchannel. **** P < 0.0001. (D) Representative images of the 3D tumor region after 24 h from the injection of CTL (in blue) into the system. Live and dead B16–OVA cells are shown in green and red, respectively. (E) Scatter plot of the percentage of dead B16-Q4R7 cells after 24 h from the injection of OT-I Themis cWT or cKO TX CTL in the fluidic microchannel. * P = 0.0231, **** P < 0.0001. (F) Representative images of the 3D tumor region after 24 h from the injection of CTL (in blue) into the system. Live and dead B16-Q4R7 cells are shown in green and red, respectively. (G) Scatter plot of the percentage of dead B16-OVA and B16-Q4R7 cells after 24 h from the injection of OT-I Themis cWT CTL in the fluidic microchannel. **** P < 0.0001. (H) Scatter plot of the percentage of dead B16-OVA and B16-Q4R7 cells after 24 h from the injection of OT-I Themis cKO TX CTL in the fluidic microchannel. **** P < 0.0001. (I) Scatter plot of the number of OT-I Themis cWT and cKO TX CTL infiltrated after 24 h in the 3D tumor region with B16-OVA. * P = 0.0369. (J) Scatter plot of the number of OT-I Themis cWT and cKO TX CTL infiltrated after 24 h in the 3D tumor region with B16-Q4R7. ** P = 0.0019. Mean ± SD values are shown. Each data point in the graphs represent the value for one region of interest. Data are from n = 5 regions of interest per device, n = 3 devices per condition and n = 2 independent experiments. Samples were compared by one-way ANOVA with multiple comparisons (C, E) and by unpaired two-tailed t test (G, H, I, J).
Microfluidic Devices, supplied by AIM Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microfluidic+device+preparation/microfluidic+devices/pmc10517225-336-7-9
Average 90 stars, based on 1 article reviews
microfluidic devices - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
BioMimetic Therapeutics microfluidic mixing device
(A) Schematic layout of the <t>microfluidic</t> device to perform 3D co-culture of B16 melanoma cells and T cells from Themis cWT or cKO OT-I mice treated with tamoxifen (TX). The central channel (in purple) represents the tumor region, whereas the lateral channels (in cyan) provide nutrients and allow for CTL injection. (B) Zoomed-in schematic of the microfluidic system. Target melanoma cells were embedded in an extracellular matrix-like hydrogel and inserted in the central microchannel flanked by two lateral channels containing cell culture medium and CTL. Live and dead B16 melanoma cells are shown in green and red, respectively. CTL are shown in blue. (C) Scatter plot of the percentage of dead B16–OVA cells after 24 h from the injection of OT-I Themis cWT or cKO TX CTL in the fluidic microchannel. **** P < 0.0001. (D) Representative images of the 3D tumor region after 24 h from the injection of CTL (in blue) into the system. Live and dead B16–OVA cells are shown in green and red, respectively. (E) Scatter plot of the percentage of dead B16-Q4R7 cells after 24 h from the injection of OT-I Themis cWT or cKO TX CTL in the fluidic microchannel. * P = 0.0231, **** P < 0.0001. (F) Representative images of the 3D tumor region after 24 h from the injection of CTL (in blue) into the system. Live and dead B16-Q4R7 cells are shown in green and red, respectively. (G) Scatter plot of the percentage of dead B16-OVA and B16-Q4R7 cells after 24 h from the injection of OT-I Themis cWT CTL in the fluidic microchannel. **** P < 0.0001. (H) Scatter plot of the percentage of dead B16-OVA and B16-Q4R7 cells after 24 h from the injection of OT-I Themis cKO TX CTL in the fluidic microchannel. **** P < 0.0001. (I) Scatter plot of the number of OT-I Themis cWT and cKO TX CTL infiltrated after 24 h in the 3D tumor region with B16-OVA. * P = 0.0369. (J) Scatter plot of the number of OT-I Themis cWT and cKO TX CTL infiltrated after 24 h in the 3D tumor region with B16-Q4R7. ** P = 0.0019. Mean ± SD values are shown. Each data point in the graphs represent the value for one region of interest. Data are from n = 5 regions of interest per device, n = 3 devices per condition and n = 2 independent experiments. Samples were compared by one-way ANOVA with multiple comparisons (C, E) and by unpaired two-tailed t test (G, H, I, J).
Microfluidic Mixing Device, supplied by BioMimetic Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microfluidic+device+preparation/microfluidic+mixing+device/pm38588850-24-9-0
Average 90 stars, based on 1 article reviews
microfluidic mixing device - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

86
Dow Corning microfluidic device preparation
(A) Schematic layout of the <t>microfluidic</t> device to perform 3D co-culture of B16 melanoma cells and T cells from Themis cWT or cKO OT-I mice treated with tamoxifen (TX). The central channel (in purple) represents the tumor region, whereas the lateral channels (in cyan) provide nutrients and allow for CTL injection. (B) Zoomed-in schematic of the microfluidic system. Target melanoma cells were embedded in an extracellular matrix-like hydrogel and inserted in the central microchannel flanked by two lateral channels containing cell culture medium and CTL. Live and dead B16 melanoma cells are shown in green and red, respectively. CTL are shown in blue. (C) Scatter plot of the percentage of dead B16–OVA cells after 24 h from the injection of OT-I Themis cWT or cKO TX CTL in the fluidic microchannel. **** P < 0.0001. (D) Representative images of the 3D tumor region after 24 h from the injection of CTL (in blue) into the system. Live and dead B16–OVA cells are shown in green and red, respectively. (E) Scatter plot of the percentage of dead B16-Q4R7 cells after 24 h from the injection of OT-I Themis cWT or cKO TX CTL in the fluidic microchannel. * P = 0.0231, **** P < 0.0001. (F) Representative images of the 3D tumor region after 24 h from the injection of CTL (in blue) into the system. Live and dead B16-Q4R7 cells are shown in green and red, respectively. (G) Scatter plot of the percentage of dead B16-OVA and B16-Q4R7 cells after 24 h from the injection of OT-I Themis cWT CTL in the fluidic microchannel. **** P < 0.0001. (H) Scatter plot of the percentage of dead B16-OVA and B16-Q4R7 cells after 24 h from the injection of OT-I Themis cKO TX CTL in the fluidic microchannel. **** P < 0.0001. (I) Scatter plot of the number of OT-I Themis cWT and cKO TX CTL infiltrated after 24 h in the 3D tumor region with B16-OVA. * P = 0.0369. (J) Scatter plot of the number of OT-I Themis cWT and cKO TX CTL infiltrated after 24 h in the 3D tumor region with B16-Q4R7. ** P = 0.0019. Mean ± SD values are shown. Each data point in the graphs represent the value for one region of interest. Data are from n = 5 regions of interest per device, n = 3 devices per condition and n = 2 independent experiments. Samples were compared by one-way ANOVA with multiple comparisons (C, E) and by unpaired two-tailed t test (G, H, I, J).
Microfluidic Device Preparation, supplied by Dow Corning, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microfluidic+device+preparation/channels+device+fabrication+microfluidic+microfluidic/pmc12743417-112-1-13
Average 86 stars, based on 1 article reviews
microfluidic device preparation - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

90
MicroFluidic Systems pdms microfluidic devices
(A) Schematic layout of the <t>microfluidic</t> device to perform 3D co-culture of B16 melanoma cells and T cells from Themis cWT or cKO OT-I mice treated with tamoxifen (TX). The central channel (in purple) represents the tumor region, whereas the lateral channels (in cyan) provide nutrients and allow for CTL injection. (B) Zoomed-in schematic of the microfluidic system. Target melanoma cells were embedded in an extracellular matrix-like hydrogel and inserted in the central microchannel flanked by two lateral channels containing cell culture medium and CTL. Live and dead B16 melanoma cells are shown in green and red, respectively. CTL are shown in blue. (C) Scatter plot of the percentage of dead B16–OVA cells after 24 h from the injection of OT-I Themis cWT or cKO TX CTL in the fluidic microchannel. **** P < 0.0001. (D) Representative images of the 3D tumor region after 24 h from the injection of CTL (in blue) into the system. Live and dead B16–OVA cells are shown in green and red, respectively. (E) Scatter plot of the percentage of dead B16-Q4R7 cells after 24 h from the injection of OT-I Themis cWT or cKO TX CTL in the fluidic microchannel. * P = 0.0231, **** P < 0.0001. (F) Representative images of the 3D tumor region after 24 h from the injection of CTL (in blue) into the system. Live and dead B16-Q4R7 cells are shown in green and red, respectively. (G) Scatter plot of the percentage of dead B16-OVA and B16-Q4R7 cells after 24 h from the injection of OT-I Themis cWT CTL in the fluidic microchannel. **** P < 0.0001. (H) Scatter plot of the percentage of dead B16-OVA and B16-Q4R7 cells after 24 h from the injection of OT-I Themis cKO TX CTL in the fluidic microchannel. **** P < 0.0001. (I) Scatter plot of the number of OT-I Themis cWT and cKO TX CTL infiltrated after 24 h in the 3D tumor region with B16-OVA. * P = 0.0369. (J) Scatter plot of the number of OT-I Themis cWT and cKO TX CTL infiltrated after 24 h in the 3D tumor region with B16-Q4R7. ** P = 0.0019. Mean ± SD values are shown. Each data point in the graphs represent the value for one region of interest. Data are from n = 5 regions of interest per device, n = 3 devices per condition and n = 2 independent experiments. Samples were compared by one-way ANOVA with multiple comparisons (C, E) and by unpaired two-tailed t test (G, H, I, J).
Pdms Microfluidic Devices, supplied by MicroFluidic Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microfluidic+device+preparation/pdms+based+microfluidic+systems/pmc04288782-44-10-66
Average 90 stars, based on 1 article reviews
pdms microfluidic devices - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
NeXstar Pharmaceuticals microfluidic device nexstar nano2
Three IOs with PEG-PLA were prepared by <t>microfluidic</t> chip to obtain IPM. si HSP47 and si HMGB1 were delivered to treat hepatic fibrosis by targeting activated hepatic stellate cells with the addition of FAPi-PEG-PLA in the formulation. Meanwhile, attenuated ABC phenomenon of IPM was observed.
Microfluidic Device Nexstar Nano2, supplied by NeXstar Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microfluidic+device+preparation/microfluidic+device+nexstar+nano2/pmc11699125-239-16-18
Average 90 stars, based on 1 article reviews
microfluidic device nexstar nano2 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
FLUIGENT Inc microfluidic flow control device fluigent mfcs-ez
Three IOs with PEG-PLA were prepared by <t>microfluidic</t> chip to obtain IPM. si HSP47 and si HMGB1 were delivered to treat hepatic fibrosis by targeting activated hepatic stellate cells with the addition of FAPi-PEG-PLA in the formulation. Meanwhile, attenuated ABC phenomenon of IPM was observed.
Microfluidic Flow Control Device Fluigent Mfcs Ez, supplied by FLUIGENT Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microfluidic+device+preparation/microfluidic+flow+control+system+mfcs+ez/pm37931072-81-7-7
Average 90 stars, based on 1 article reviews
microfluidic flow control device fluigent mfcs-ez - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Precigenome LLC microfluidic device
Three IOs with PEG-PLA were prepared by <t>microfluidic</t> chip to obtain IPM. si HSP47 and si HMGB1 were delivered to treat hepatic fibrosis by targeting activated hepatic stellate cells with the addition of FAPi-PEG-PLA in the formulation. Meanwhile, attenuated ABC phenomenon of IPM was observed.
Microfluidic Device, supplied by Precigenome LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microfluidic+device+preparation/glass+microfluidic+mixer+chip/bio_rxiv__2024__09__01__610730-134-6-10
Average 90 stars, based on 1 article reviews
microfluidic device - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Precigenome LLC nanogenerator flex-m
Three IOs with PEG-PLA were prepared by <t>microfluidic</t> chip to obtain IPM. si HSP47 and si HMGB1 were delivered to treat hepatic fibrosis by targeting activated hepatic stellate cells with the addition of FAPi-PEG-PLA in the formulation. Meanwhile, attenuated ABC phenomenon of IPM was observed.
Nanogenerator Flex M, supplied by Precigenome LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microfluidic+device+preparation/nanogenerator+flex/pm39415058-290-31-36
Average 90 stars, based on 1 article reviews
nanogenerator flex-m - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

86
10X Genomics chromium controller microfluidics device
Three IOs with PEG-PLA were prepared by <t>microfluidic</t> chip to obtain IPM. si HSP47 and si HMGB1 were delivered to treat hepatic fibrosis by targeting activated hepatic stellate cells with the addition of FAPi-PEG-PLA in the formulation. Meanwhile, attenuated ABC phenomenon of IPM was observed.
Chromium Controller Microfluidics Device, supplied by 10X Genomics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microfluidic+device+preparation/chromium+controller/pm37777519-322-10-14
Average 86 stars, based on 1 article reviews
chromium controller microfluidics device - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

90
FLUIGENT Inc microfluidic flow control device
Three IOs with PEG-PLA were prepared by <t>microfluidic</t> chip to obtain IPM. si HSP47 and si HMGB1 were delivered to treat hepatic fibrosis by targeting activated hepatic stellate cells with the addition of FAPi-PEG-PLA in the formulation. Meanwhile, attenuated ABC phenomenon of IPM was observed.
Microfluidic Flow Control Device, supplied by FLUIGENT Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microfluidic+device+preparation/microfluidic+flow+control+system/pm36272514-89-6-6
Average 90 stars, based on 1 article reviews
microfluidic flow control device - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
NeXstar Pharmaceuticals microfluidic-chip device
Three IOs with PEG-PLA were prepared by <t>microfluidic</t> chip to obtain IPM. si HSP47 and si HMGB1 were delivered to treat hepatic fibrosis by targeting activated hepatic stellate cells with the addition of FAPi-PEG-PLA in the formulation. Meanwhile, attenuated ABC phenomenon of IPM was observed.
Microfluidic Chip Device, supplied by NeXstar Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microfluidic+device+preparation/microfluidic+chip+nexstar/pmc12254852-57-1-4
Average 90 stars, based on 1 article reviews
microfluidic-chip device - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
National Institute of Standards and Technology plastic microfluidic devices
Three IOs with PEG-PLA were prepared by <t>microfluidic</t> chip to obtain IPM. si HSP47 and si HMGB1 were delivered to treat hepatic fibrosis by targeting activated hepatic stellate cells with the addition of FAPi-PEG-PLA in the formulation. Meanwhile, attenuated ABC phenomenon of IPM was observed.
Plastic Microfluidic Devices, supplied by National Institute of Standards and Technology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microfluidic+device+preparation/microfluidic+devices/pm10815942-93-45-31
Average 90 stars, based on 1 article reviews
plastic microfluidic devices - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


(A) Schematic layout of the microfluidic device to perform 3D co-culture of B16 melanoma cells and T cells from Themis cWT or cKO OT-I mice treated with tamoxifen (TX). The central channel (in purple) represents the tumor region, whereas the lateral channels (in cyan) provide nutrients and allow for CTL injection. (B) Zoomed-in schematic of the microfluidic system. Target melanoma cells were embedded in an extracellular matrix-like hydrogel and inserted in the central microchannel flanked by two lateral channels containing cell culture medium and CTL. Live and dead B16 melanoma cells are shown in green and red, respectively. CTL are shown in blue. (C) Scatter plot of the percentage of dead B16–OVA cells after 24 h from the injection of OT-I Themis cWT or cKO TX CTL in the fluidic microchannel. **** P < 0.0001. (D) Representative images of the 3D tumor region after 24 h from the injection of CTL (in blue) into the system. Live and dead B16–OVA cells are shown in green and red, respectively. (E) Scatter plot of the percentage of dead B16-Q4R7 cells after 24 h from the injection of OT-I Themis cWT or cKO TX CTL in the fluidic microchannel. * P = 0.0231, **** P < 0.0001. (F) Representative images of the 3D tumor region after 24 h from the injection of CTL (in blue) into the system. Live and dead B16-Q4R7 cells are shown in green and red, respectively. (G) Scatter plot of the percentage of dead B16-OVA and B16-Q4R7 cells after 24 h from the injection of OT-I Themis cWT CTL in the fluidic microchannel. **** P < 0.0001. (H) Scatter plot of the percentage of dead B16-OVA and B16-Q4R7 cells after 24 h from the injection of OT-I Themis cKO TX CTL in the fluidic microchannel. **** P < 0.0001. (I) Scatter plot of the number of OT-I Themis cWT and cKO TX CTL infiltrated after 24 h in the 3D tumor region with B16-OVA. * P = 0.0369. (J) Scatter plot of the number of OT-I Themis cWT and cKO TX CTL infiltrated after 24 h in the 3D tumor region with B16-Q4R7. ** P = 0.0019. Mean ± SD values are shown. Each data point in the graphs represent the value for one region of interest. Data are from n = 5 regions of interest per device, n = 3 devices per condition and n = 2 independent experiments. Samples were compared by one-way ANOVA with multiple comparisons (C, E) and by unpaired two-tailed t test (G, H, I, J).

Journal: Life Science Alliance

Article Title: Themis controls T cell activation, effector functions, and metabolism of peripheral CD8 + T cells

doi: 10.26508/lsa.202302156

Figure Lengend Snippet: (A) Schematic layout of the microfluidic device to perform 3D co-culture of B16 melanoma cells and T cells from Themis cWT or cKO OT-I mice treated with tamoxifen (TX). The central channel (in purple) represents the tumor region, whereas the lateral channels (in cyan) provide nutrients and allow for CTL injection. (B) Zoomed-in schematic of the microfluidic system. Target melanoma cells were embedded in an extracellular matrix-like hydrogel and inserted in the central microchannel flanked by two lateral channels containing cell culture medium and CTL. Live and dead B16 melanoma cells are shown in green and red, respectively. CTL are shown in blue. (C) Scatter plot of the percentage of dead B16–OVA cells after 24 h from the injection of OT-I Themis cWT or cKO TX CTL in the fluidic microchannel. **** P < 0.0001. (D) Representative images of the 3D tumor region after 24 h from the injection of CTL (in blue) into the system. Live and dead B16–OVA cells are shown in green and red, respectively. (E) Scatter plot of the percentage of dead B16-Q4R7 cells after 24 h from the injection of OT-I Themis cWT or cKO TX CTL in the fluidic microchannel. * P = 0.0231, **** P < 0.0001. (F) Representative images of the 3D tumor region after 24 h from the injection of CTL (in blue) into the system. Live and dead B16-Q4R7 cells are shown in green and red, respectively. (G) Scatter plot of the percentage of dead B16-OVA and B16-Q4R7 cells after 24 h from the injection of OT-I Themis cWT CTL in the fluidic microchannel. **** P < 0.0001. (H) Scatter plot of the percentage of dead B16-OVA and B16-Q4R7 cells after 24 h from the injection of OT-I Themis cKO TX CTL in the fluidic microchannel. **** P < 0.0001. (I) Scatter plot of the number of OT-I Themis cWT and cKO TX CTL infiltrated after 24 h in the 3D tumor region with B16-OVA. * P = 0.0369. (J) Scatter plot of the number of OT-I Themis cWT and cKO TX CTL infiltrated after 24 h in the 3D tumor region with B16-Q4R7. ** P = 0.0019. Mean ± SD values are shown. Each data point in the graphs represent the value for one region of interest. Data are from n = 5 regions of interest per device, n = 3 devices per condition and n = 2 independent experiments. Samples were compared by one-way ANOVA with multiple comparisons (C, E) and by unpaired two-tailed t test (G, H, I, J).

Article Snippet: Collagen solution was prepared and inserted in microfluidic devices (AIM Biotech) following a previously described protocol ( ).

Techniques: Co-Culture Assay, Injection, Cell Culture, Two Tailed Test

Three IOs with PEG-PLA were prepared by microfluidic chip to obtain IPM. si HSP47 and si HMGB1 were delivered to treat hepatic fibrosis by targeting activated hepatic stellate cells with the addition of FAPi-PEG-PLA in the formulation. Meanwhile, attenuated ABC phenomenon of IPM was observed.

Journal: Nature Communications

Article Title: Ionizable polymeric micelles (IPMs) for efficient siRNA delivery

doi: 10.1038/s41467-024-55721-w

Figure Lengend Snippet: Three IOs with PEG-PLA were prepared by microfluidic chip to obtain IPM. si HSP47 and si HMGB1 were delivered to treat hepatic fibrosis by targeting activated hepatic stellate cells with the addition of FAPi-PEG-PLA in the formulation. Meanwhile, attenuated ABC phenomenon of IPM was observed.

Article Snippet: The aqueous phase and organic phase were mixed at a flow rate of 3:1 using a microfluidic device (NEXSTAR NANO2, C10-1).

Techniques: Formulation